Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
Radiology
•
Inflammatory arthritis
•
Nuclear Medicine
When would you consider utilizing bone scintigraphy in the assessment of inflammatory arthritis?
Answer from: at Community Practice
When it's a case of negative RA disease or when considering a neoplastic, gammopathy with myeloma...
Sign in or Register to read more
Answer from: at Community Practice
I would also consider using triple phase bone scan to assess the blood pool phase which may help determine sites of active inflammation. This may also help guide sites for intervention/injection.
Sign in or Register to read more
14606
22338
Related Questions
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
When screening for malignancy, do you order CT with contrast (or) both with and without contrast?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?
When trying to increase infliximab for active disease (inflammatory arthritis or sarcoidosis), do you prefer to increase dosage or reduce frequency between doses?
How do you approach vaccination, particularly the use of live vaccines such as yellow fever, in a patient with rheumatoid arthritis receiving a TNF inhibitor who is planning travel to Africa?
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
Do you continue TNF inhibitors in patients with a new diagnosis of CLL?